🇺🇸 FDA
Patent

US 12018001

Pyrimidine cyclohexenyl glucocorticoid receptor modulators

granted A61PA61P1/16A61P35/00

Quick answer

US patent 12018001 (Pyrimidine cyclohexenyl glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/16, A61P35/00